시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 수탁 개발 제조 기관 시장 보고서(2025년)
Contract Development Manufacturing Organizations Global Market Report 2025
상품코드 : 1648655
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,496,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,390,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,284,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 수탁 개발 제조 기관 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 13.2%, 시장 규모는 4,553억 6,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 맞춤형 의료의 채용 가속, 생물제제와 바이오시밀러 수요 증가, 연구개발 아웃소싱에 대한 주목 증가, 의약품 제조에 영향을 미치는 규제의 변경 등에 기인할 것으로 예상됩니다. 예측 기간의 주요 동향으로는 제조 공정에서의 기술적 진보, 제조 공정에서의 디지털 기술의 통합, 지속가능하고 환경 친화적인 관행으로 전환, 가상 분산 CDMO 모델의 대두, 제조 업무 최적화에 있어서의 데이터 분석의 중요성 증가 등을 들 수 있습니다.

만성 질환과 노인 인구 증가로 인한 의약품 수요 증가는 수탁 개발 제조 기관 시장의 성장에 기여했습니다. 만성 질환과 노인 인구가 증가함에 따라 제약 회사는 생물 제제 및 바이오시밀러를 신속하게 제조할 수 있으며, 대부분의 제약 회사는 회사의 작업, 운영 및 테스트를 처리 및 조정하기 위해 계약 기반으로 운영되는 수탁 생산 및 제조 기관과 계약을 맺고 있습니다. 예를 들어 세계보건기구(WHO)에 따르면 만성질환의 유병률은 2050년까지 1억 4,200만 명이 될 것으로 예상됩니다. 또한 60세 이상의 세계 인구는 20억 명으로 증가할 것으로 예측됩니다. 그러므로 의약품에 대한 수요 증가가 수탁 개발 제조 기관 시장의 성장을 견인할 것으로 예측됩니다.

임상시험 증가는 향후 수탁 개발 제조 기관 시장의 성장을 가속할 것으로 예측됩니다. 의약품 개발을 위한 임상시험은 신약이나 치료법의 안전성, 효능, 잠재적인 부작용을 인간에서 평가하기 위해 실시되는 연구조사입니다. 임상시험을 통해 CDMO에 새로운 수익원을 제공하고, 서비스를 확대하고, 제약기업과의 장기적인 파트너십으로 이어지고, 명성을 높이고, 협력관계를 구축할 수 있습니다. 예를 들어, 캐나다에 본사를 두고 생명과학에 관한 웹 세미나와 가상 이벤트 제공을 전문으로 하는 Xtalks에 따르면, 2023년 5월 17일 현재 ClinicalTrials.gov에 등록된 임상시험은 45만 2,604건에 이릅니다. 등록된 전체 중 64,838건의 시험이 현재 참가자를 모집하고 있으며, 이는 2021년에 등록된 36만 5000건의 시험수로부터 증가하고 있습니다. 따라서 임상시험수 증가는 수탁 개발 제조 기관 시장의 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 시장의 최근 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Contract development manufacturing organizations refer to businesses that work on a contract basis with the pharmaceutical sector to provide medication development and manufacturing services. These businesses enable the pharmaceutical industry to outsource some of its operations, freeing up crucial time to concentrate on medication development and marketing.

The contract development manufacturing organizations are segmented by service into CMO, CRO; by product into small molecules, biologics and by end user into big pharma, small and mid-size pharma, generic pharmaceutical companies, and other end users.

The contract development manufacturing organizations market research report is one of a series of new reports from The Business Research Company that provides contract development manufacturing organizations market statistics, including contract development manufacturing organizations industry global market size, regional shares, competitors with a contract development manufacturing organizations market share, detailed contract development manufacturing organizations market segments, market trends and opportunities, and any further data you may need to thrive in the contract development manufacturing organizations industry. This contract development manufacturing organizations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The contract development manufacturing organizations market size has grown rapidly in recent years. It will grow from $247.19 billion in 2024 to $277.29 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to growing complexity and specialization in drug development, increased demand for outsourcing inThe pharmaceutical industry, cost containment and efficiency pressures, advancements in biotechnology and pharmaceutical research, globalization of The pharmaceutical and biopharmaceutical industries.

The contract development manufacturing organizations market size is expected to see rapid growth in the next few years. It will grow to $455.36 billion in 2029 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to accelerated adoption of personalized medicine, rising demand for biologics and biosimilars, increased focus on research and development outsourcing, regulatory changes impacting pharmaceutical manufacturing. Major trends in the forecast period include technological advancements in manufacturing processes, integration of digital technologies in manufacturing processes, shift towards sustainable and environmentally friendly practices, rise of virtual and decentralized CDMO models, growing importance of data analytics in optimizing manufacturing operations.

The growing demand for pharmaceutical products due to the increase in chronic diseases and the geriatric population contributed to the growth of the contract development manufacturing organizations market. Rising chronic diseases and geriatric population has enabled pharmaceutical companies to manufacture biologics and biosimilars quickly, and most pharmaceutical firms have contracted contract production and manufacturing organizations operating on a contractual basis to handle and coordinate the company's tasks, operations and tests. For instance, according to the World Health Organization, the prevalence of chronic diseases rose is expected to grow 142. 66 million by 2050 and the world's population of 60 years and older is projected to rise to 2 billion. Therefore, the growing demand for pharmaceutical products is projected to drive the growth of the contract development manufacturing organizations market.

The increasing number of clinical trials is expected to propel the growth of the contract development manufacturing organizations market going forward. Clinical trials for drug development are research studies conducted to evaluate the safety, efficacy, and potential side effects of a new drug or treatment in humans. Engaging in clinical trials can provide an additional revenue stream for CDMOs, expand services, can lead to long-term partnerships with pharmaceutical companies, enhance reputation, and can establish collaborative relationships. For instance, in May 2023, according to Xtalks, a Canada-based company specializing in providing life science webinars and virtual events, there are 452,604 clinical studies that have been registered on ClinicalTrials. gov as of May 17, 2023. 64,838 studies out of the total number that have been registered are actively seeking participants which is an increase of 365,000 registered trials in 2021. Therefore, the increasing number of clinical trials is driving the growth of the contract development manufacturing organizations market.

The introduction of custom solutions is a key trend gaining popularity in the market for contract development and manufacturing organizations. Contract development and manufacturing companies focus on the implementation of custom technologies to address the unique needs of individual research applications. For instance, in October 2022, Aenova Holding GmbH, a Germany based pharmaceutical and healthcare contract manufacturing company, entered into a strategic partnership with Microcaps, a Switzerland based pharmaceutical company. Through this collaboration, both companies can develop and produce medicines, food supplements, and many other things more quickly and better. Microcaps will share their knowledge of cutting-edge, highly accurate microencapsulation and utilizing a patented technological platform, the technique allows for customized formulations, such as in release, protective coating, and texture.

Major companies operating in the contract development and manufacturing organizations market are focusing on innovative developments such as Lifera to drive revenues in their market. Lifera, a commercial-scale contract development and manufacturing organization (CDMO). For instance, in June 2023, Public Investment Fund (PIF), Saudi Arabia's global investment organization launched Lifera. The production of vital biopharmaceutical goods, such as insulin, vaccinations, monoclonal antibodies, plasma treatments, cell and gene therapies, and cutting-edge small chemicals, will be Lifera's primary focus. To increase local capacity and support domestic manufacturing in this industry, the corporation will also form alliances with top domestic and foreign businesses and draw in specific investments. Driving formulation development, medication development, and manufacturing are some of Lifera's objectives.

In February 2022, Recipharm AB, a Sweden based pharmaceutical contract development and manufacturing company, acquired Arranta Bio for an undisclosed amount. Through this acquisition, Recipharm forms the basis of a plan to offer contract development and manufacturing services that are scientifically unique to innovative drug developers in the biologics industry, increases its capabilities in new biologics modalities, and will deliver a high level of diversification across many technologies and modalities. Arranta Bio is a US-based contract development and manufacturing organization (CDMO) that collaborates with businesses looking to develop and produce novel medicines and complicated biological pharmaceuticals.

Major companies operating in the contract development manufacturing organizations market include Recipharm AB, AbbVie Contract Manufacturing LLC, Almac Group Limited, Baxter BioPharma Solutions LLC, Boehringer Ingelheim International GmbH, Catalent Pharma Solutions Inc., CMIC Holdings Co. Ltd., Covance Inc., Evotec SE, Famar Health Care Services Madrid SA, Jubilant Life Sciences Limited, Lonza Group Ltd., Patheon UK Limited, Pfizer CentreOne, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, Advanced BioScience Laboratories Inc., Adare Pharmaceuticals Inc., Aenova Holding GmbH, Ajinomoto Bio-Pharma Services, Albany Molecular Research Inc, Cambrex Corporation, CordenPharma International GmbH, EirGen Pharma Limited, Grand River Aseptic Manufacturing, Hovione LLC, Metrics Contract Services, NextPharma Technologies Holding Limited, Nitto Avecia Pharma Services Inc., Piramal Pharma Solutions Inc., Siegfried Holding AG, Sterling Biotech Limited, Therapure Biopharma Inc., Velesco Pharmaceutical Services, WuXi PharmaTech (Cayman) Inc.

North America was the largest region in contract development manufacturing organizations market in 2024. The regions covered in the contract development manufacturing organizations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the contract development manufacturing organizations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The contract development manufacturing organizations market includes revenues earned by entities by formulation, analytical services, blending, coating, and converting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contract Development Manufacturing Organizations Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on contract development manufacturing organizations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for contract development manufacturing organizations ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The contract development manufacturing organizations market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Contract Development Manufacturing Organizations Market Characteristics

3. Contract Development Manufacturing Organizations Market Trends And Strategies

4. Contract Development Manufacturing Organizations Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Contract Development Manufacturing Organizations Growth Analysis And Strategic Analysis Framework

6. Contract Development Manufacturing Organizations Market Segmentation

7. Contract Development Manufacturing Organizations Market Regional And Country Analysis

8. Asia-Pacific Contract Development Manufacturing Organizations Market

9. China Contract Development Manufacturing Organizations Market

10. India Contract Development Manufacturing Organizations Market

11. Japan Contract Development Manufacturing Organizations Market

12. Australia Contract Development Manufacturing Organizations Market

13. Indonesia Contract Development Manufacturing Organizations Market

14. South Korea Contract Development Manufacturing Organizations Market

15. Western Europe Contract Development Manufacturing Organizations Market

16. UK Contract Development Manufacturing Organizations Market

17. Germany Contract Development Manufacturing Organizations Market

18. France Contract Development Manufacturing Organizations Market

19. Italy Contract Development Manufacturing Organizations Market

20. Spain Contract Development Manufacturing Organizations Market

21. Eastern Europe Contract Development Manufacturing Organizations Market

22. Russia Contract Development Manufacturing Organizations Market

23. North America Contract Development Manufacturing Organizations Market

24. USA Contract Development Manufacturing Organizations Market

25. Canada Contract Development Manufacturing Organizations Market

26. South America Contract Development Manufacturing Organizations Market

27. Brazil Contract Development Manufacturing Organizations Market

28. Middle East Contract Development Manufacturing Organizations Market

29. Africa Contract Development Manufacturing Organizations Market

30. Contract Development Manufacturing Organizations Market Competitive Landscape And Company Profiles

31. Contract Development Manufacturing Organizations Market Other Major And Innovative Companies

32. Global Contract Development Manufacturing Organizations Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Contract Development Manufacturing Organizations Market

34. Recent Developments In The Contract Development Manufacturing Organizations Market

35. Contract Development Manufacturing Organizations Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기